Podcast Series - - BioPharm International


Podcast Series

BioPharm International Supplements

UPLC, QTof, HDMS, and more: A practical guide to the hottest techniques driving the future of biopharmaceutical science

In this continuing podcast series, Laura Bush, editor-in-chief of BioPharm International, interviews Waters scientists about current trends in biopharmaceutical analysis.

Episode 1: Current challenges in oligonucleotide analysis

We discuss some of the primary analytical challenges faced by oligotherapeutic and oligodiagnostic manufacturers for characterizing and quantitating oligonucleotides.

Episode 2: Getting more specificity in host cell protein analysis using proteomics approaches

In this podcast, we introduce the capabilities added by the analysis of residual host cell proteins by novel LC/MS techniques, providing more information on which an organization can act in this challenging application area.

Episode 3: Advances in glycan analysis

In this podcast, we provide a firm knowledge of the latest technological innovations in LC and LC/MS that have been designed to address and advance the very specific needs of the many applications areas in the biopharmaceutical laboratory.

Episode 4: Why ion mobility is shaping the future

This podcast will show how IMS has enabled studies of protein conformation, pegylated proteins, top-down sequencing, and characterization of protein glycosylation.

Episode 5: Advancing peptide mapping with informatics support for multiplexed peptide fragmentation data

Selecting an efficient peptide mapping LC/MS methodology and proper informatics tools are critical for obtaining quick and complete information about a biotherapeutic protein.

To listen to these podcasts, go to: http://www.biopharminternational.com/biopharm/static/staticHtml.jsp?id=569758

blog comments powered by Disqus



FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
IMS: Global Spending on Medicines to Rise 30% by 2018
November 24, 2014
Author Guidelines
Source: BioPharm International Supplements,
Click here